Sofinnova Partners — 2015 Investments
3 investments dated 2015 · listed companies and verified rows first · show all
Biotech
Co-investorsKurma PartnersJohnson & Johnson Innovation – JJDCM VenturesSR One Capital ManagementEQT Life Sciences
GenSight Biologics develops clinical-stage gene therapy treatments, with a lead candidate (GS010/LUMEVOQ) in development for rare genetic diseases.
BiotechDigital HealthHealthtechMedical DevicesParis, FR
Bernard Gilly(Executive Officer, Director)inJean-Philippe Combal(Executive Officer)inThomas Gidoin(Executive Officer)Didier Pruneau(Executive Officer)inNitza Thomasson(Executive Officer)in
BoardFlorent Gros(Director)
Co-investorsAgoranovAbingworth
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Comet Biorefining
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.





